From left to right: Katie Adams, assistant editor at MedCity News; and Jennifer Thompson, vice president of U.S. aortic sales at Medtronic The process of commercializing a new medical device is ...

COLUMBUS, Ohio – The Ohio State University Wexner Medical Center is the first site in the U.S. to enroll a patient in an international trial testing whether a novel pacemaker programming strategy can ...

Medtronic's shares have sharply rallied over the last six months. The medtech giant's growth catalysts include a best-in-class product (Affera) in a fast-growing $11 billion space and a massive ...

Athens, Tenn.-based Starr Regional Medical Center completed its first implantation of Medtronic’s Micra leadless pacemaker, a device for patients with slow heart rhythms. The minimally invasive ...

GLASGOW, SCOTLAND - MAY 22: Dr Catherine Calderwood (2L), Chief Medical Officer for Scotland, Professor Sir Pete Downes, Principal and Vice Chancellor (2R), Dr Vanessa Kay, Co-Director DIHS (R) and Dr ...

While there is no cure for Parkinson’s disease, there’s now a better way to control its involuntary muscle movements. In February, the FDA approved Medtronic’s BrainSense adaptive deep brain ...

The Ohio State University Wexner Medical Center is the first site in the U.S. to enroll a patient in an international trial testing whether a novel pacemaker programming strategy can ease symptoms and ...

“From a patient’s perspective, the implant looks no different from a routine pacemaker procedure. What sets this apart is the programming, which gently raises the heart rate in a targeted way. That ...